Invitra CBSC SuspensionTM is an umbilical cord blood derived stem cell product. The product consists of a cord blood stem cell population that includes hematopoietic stem cells (HSC), and mesenchymal stems cells (MSC). These stem cells have the capacity to self-renewal, release growth factors and cytokines, as well as differentiate into more mature cells.
As an extension of fetal cells, umbilical cord blood cells exhibit high plasticity. Umbilical cord stem cells have been used for over twenty years for hematopoietic stem cell reconstitution as a substitution for bone marrow reconstitution.2 Additionally, due to the high plasticity of umbilical cord cells, there is significantly decreased risk of graft-versus- host disease (GVHD) and if GVHD does occur it is less severe than most other types of transplants.3,4
All of our donors are pre-screened through medical record review and evaluation of pre-natal tests. Eligibility is confirmed through behavior risk assessment, physical assessment, donor medical history, review of blood test results, and communicable disease testing.